home / stock / cgix / cgix news


CGIX News and Press, Cancer Genetics Inc. From 06/27/20

Stock Information

Company Name: Cancer Genetics Inc.
Stock Symbol: CGIX
Market: NASDAQ

Menu

CGIX CGIX Quote CGIX Short CGIX News CGIX Articles CGIX Message Board
Get CGIX Alerts

News, Short Squeeze, Breakout and More Instantly...

CGIX - Mixed shelf roundup - healthcare

The following healthcare companies have filed for mixed shelf offerings: More news on: Veru Inc., Cancer Genetics, Inc., Trevi Therapeutics, Inc., Healthcare stocks news, , Read more ...

CGIX - Cancer Genetics reports Q1 results

Cancer Genetics (NASDAQ: CGIX ): Q1 GAAP EPS of -$0.56. More news on: Cancer Genetics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

CGIX - Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates

RUTHERFORD, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced financial and operating results for the quarter ended March 31, 2020. ...

CGIX - Cancer Genetics reports Q4 results

Cancer Genetics (NASDAQ: CGIX ): Q4 GAAP EPS of -$0.14. Revenue of $1.9M (+11.8% Y/Y) Shares +7% PM. Press Release More news on: Cancer Genetics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,

CGIX - Cancer Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Strategic Business Updates

RUTHERFORD, N.J., June 01, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2019. OPERA...

CGIX - IPO Update: Lantern Pharma Readies $25 Million IPO

Quick Take Lantern Pharma ( LTRN ) intends to raise $25 million in gross proceeds from an IPO of its common stock, per an amended registration statement . The company is advancing a pipeline of drug treatment candidates identified by its proprietary RADR platform. LTRN believes it can b...

CGIX - Lantern Pharma Starts U.S. IPO Process

Quick Take Lantern Pharma ( LTRN ) has filed to raise $28.75 million in an IPO of its common stock, according to an S-1 registration statement . The firm is developing a pipeline of drug candidates for the treatment of prostate, lung and other cancers. LTRN seeks to use its proprietary ...

CGIX - CIM, GLNG, TWO and LADR among midday movers

Gainers:  Sasol (NYSE: SSL ) +88% . More news on: Sasol Limited, Western Asset Mortgage Capital Corporation, Caleres, Inc., Stocks on the move, , Read more ...

CGIX - NRZ, TWO, SRNE and CNX among midday movers

Gainers:  Camber Energy (NYSEMKT: CEI ) +61% . More news on: Camber Energy, Inc., Cancer Genetics, Inc., Micron Solutions, Inc., Stocks on the move, , Read more ...

CGIX - Cancer Genetics Issues Letter to Shareholders

RUTHERFORD, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics” or the “Company”), a leader in drug discovery and preclinical oncology and immuno-oncology services, today published a letter to shareholders from its Chie...

Previous 10 Next 10